MedPath

A study to assess the effect of tools on medication adherence in heart failure patients

Phase 2
Conditions
Health Condition 1: I509- Heart failure, unspecified
Registration Number
CTRI/2018/10/015956
Lead Sponsor
AIIMS
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1) Age 18 to 60 years.

2) NYHA class 2 or 3 heart failure patients of either gender visiting the Cardiology OPD .

3) Referred patients from other clinics having previous prescription.

4) Participant willing to give informed consent.

Exclusion Criteria

1) Patient already recruited for other trial.

2) Patients with major organ dysfunction like renal dysfunction (Blood Urea > 50mg%,

S.Creatinine > 1.8mg%) hepatic dysfunction (AST/ ALT/ ALP/ Total S. Bilirubin > 3 times the

upper normal limit).

3) Pregnancy and lactation.

4) With other co-morbid conditions like uncontrolled diabetes mellitus, uncontrolled

hypertension and malignancy.

5) Patients with rapidly progressing disease

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Improvement in medication adherence by measuring change in Morisky, Green, and Levine (MGL) Adherence Scale score.Timepoint: Baseline and 12 weeks
Secondary Outcome Measures
NameTimeMethod
Improvement in patient functional capacity by measuring change in Likert score.Timepoint: At baseline and follow up after 12 weeks.
© Copyright 2025. All Rights Reserved by MedPath